Atara Biotherapeutics
ATRA
ATRA
111 hedge funds and large institutions have $535M invested in Atara Biotherapeutics in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 22 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 117 → 111 (-6)
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
47% less capital invested
Capital invested by funds: $1.01B → $535M (-$472M)
Holders
111
Holding in Top 10
1
Calls
$717K
Puts
$299K
Top Buyers
| 1 | +$9.92M | |
| 2 | +$6.38M | |
| 3 | +$5.49M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$5.15M |
| 5 |
Morgan Stanley
New York
|
+$4.51M |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$8.18M | |
| 3 | -$6.94M | |
| 4 |
BM
Bridger Management
New York
|
-$5.84M |
| 5 |
CFM
Coronation Fund Managers
Cape Town,
South Africa
|
-$3.26M |